Health
Team redesigns COVID-19 Spike protein for more stable vaccines – Drug Target Review
Researchers have modified the COVID-19 S protein for use in vaccines, which produces up to 10 times more protein than that of an earlier synthetic versions.
Posted: 24 July 2020 | Victoria Rees (Drug Target Review) | No comments yet
Researchers have modified the COVID-19 Spike protein for use in vaccines, which produces up to 10 times more protein than that of an earlier synthetic versions.
A team at The University of Texas (UT) at Austin, US, has successfully redesigned a key protein from SARS-CoV-2, the virus causing the COVID-19 pandemic. They say the modification could enable much faster and more stable production of vaccines to tackle the nov…
Continue Reading